Avidity Partners Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-80,700
| Closed | -$14.3M | – | 64 |
|
|
2024
Q4 | $14.3M | Sell |
80,700
-19,300
| -19% | -$3.43M | 1.41% | 32 |
|
|
2024
Q3 | $19.7M | Sell |
100,000
-177,800
| -64% | -$35.1M | 1.01% | 39 |
|
|
2024
Q2 | $47.6M | Buy |
277,800
+50,800
| +22% | +$8.71M | 2.02% | 16 |
|
|
2024
Q1 | $41.3M | Sell |
227,000
-57,405
| -20% | -$10.5M | 1.33% | 26 |
|
|
2023
Q4 | $44.1M | Buy |
+284,405
| New | +$44.1M | 1.61% | 26 |
|
|
2023
Q3 | – | Sell |
-518,400
| Closed | -$69.8M | – | 84 |
|
|
2023
Q2 | $69.8M | Buy |
+518,400
| New | +$69.8M | 2.44% | 9 |
|
|
2022
Q3 | – | Sell |
-755,000
| Closed | -$116M | – | 97 |
|
|
2022
Q2 | $116M | Sell |
755,000
-711,100
| -49% | -$109M | 2.65% | 16 |
|
|
2022
Q1 | $238M | Sell |
1,466,100
-518,900
| -26% | -$84.1M | 4.95% | 2 |
|
|
2021
Q4 | $269M | Buy |
1,985,000
+371,800
| +23% | +$50.3M | 5.7% | 1 |
|
|
2021
Q3 | $174M | Buy |
1,613,200
+128,800
| +9% | +$13.9M | 3.86% | 3 |
|
|
2021
Q2 | $167M | Sell |
1,484,400
-592,800
| -29% | -$66.8M | 4.52% | 2 |
|
|
2021
Q1 | $225M | Buy |
2,077,200
+721,200
| +53% | +$78M | 6.21% | 1 |
|
|
2020
Q4 | $145M | Sell |
1,356,000
-166,800
| -11% | -$17.9M | 4.72% | 3 |
|
|
2020
Q3 | $133M | Sell |
1,522,800
-22,600
| -1% | -$1.98M | 6.19% | 1 |
|
|
2020
Q2 | $152M | Buy |
1,545,400
+1,068,400
| +224% | +$105M | 9.72% | 1 |
|
|
2020
Q1 | $36.3M | Buy |
477,000
+383,000
| +407% | +$29.2M | 5.02% | 3 |
|
|
2019
Q4 | $8.32M | Buy |
+94,000
| New | +$8.32M | 5.24% | 4 |
|